Pharmacy in Focus: Navigating GLP-1 demand, cost, and sustainability
With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.
Read More
Research: Addressing cardiodiabesity at the household level could lower cost trend
Research suggests that combatting cardiodiabesity at the family and household level could further improve health outcomes and lower costs.
Read More
Study: Cardiodiabesity prevention key to improving health outcomes and lowering costs
The Evernorth Research Institute analyzed aggregated and anonymized data of almost 5 million insured individuals to understand the prevalence of "cardiodiabesity" — a condition which encompasses cardi...
Read More
Study: Progression of cardiodiabesity increases care utilization and costs
The Evernorth Research Institute’s latest cardiodiabesity report helps illustrate sites of care where preventive interventions can make the greatest financial impact.
Read More
Understanding cardiodiabesity in women
As employers strive to maintain a healthy and productive workforce, addressing and understanding the prevalence of cardiodiabesity in women is critical.
Read More
Enhancing health outcomes and savings through value-based solutions
Patient engagement paired with cost-containment strategies drives better health outcomes and reduces the financial burden for plan sponsors.
Read More